Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1

Gao,Zilong; Zhang,Yaqian; Zhou,Heng; Lv,Juan

doi:10.3892/ijo.2019.4894

Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1

Authors:
- Zilong Gao
- Yaqian Zhang
- Heng Zhou
- Juan Lv
View Affiliations

Affiliations: Dongfeng Stomatological Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Pathogen Biology, College of Basic Medical Sciences, Wuhan, Hubei 430060, P.R. China, Department of Pathology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: November 18, 2019 https://doi.org/10.3892/ijo.2019.4894
Pages: 273-282

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, accounts for >90% of all diagnosed oral cancer cases. Baicalein, a naturally derived compound, has been shown to alter p65 and the nuclear factor (NF)‑κB pathway, thus exerting cytotoxic effects on various tumor cell types. However, the mechanism of action of baicalein in OSCC has not been fully elucidated. In the present study, the proliferation of OSCC cells treated with baicalein was examined using a CCK‑8 assay. The effects of baicalein on the cell cycle and apoptosis of OSCC cells were determined by flow cytometric analyses. The expression of specificity protein 1 (Sp1), p65 and p50 at the mRNA and protein levels was determined by reverse transcription‑quantitative PCR and western blot analysis, respectively. The results of the present study demonstrated that baicalein suppresses the proliferation of OSCC cell lines in vivo and in vitro. Baicalein also induced apoptosis of OSCC cells and arrested the cell cycle at the G0/G1 phase. Baicalein inhibited the expression of Sp1, p65 and p50 by downregulating the relative mRNA levels. Baicalein reduced the activity of NF‑κB in OSCC cells. Knockdown of Sp1 also resulted in reduced expression of p65 and p50. In addition, Sp1 silencing enhanced the effects of baicalein. In conclusion, the present study demonstrated that baicalein suppresses the growth of OSCC cells through an Sp1/NF‑κB‑dependent mechanism.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
2	Sinevici N and O'Sullivan J: Oral cancer: Deregulated molecular events and their use as biomarkers. Oral Oncol. 61:12–18. 2016. View Article : Google Scholar : PubMed/NCBI
3	Braakhuis BJ, Leemans CR and Visser O: Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989-2011. Oral Oncol. 50:670–675. 2014. View Article : Google Scholar : PubMed/NCBI
4	Choi EO, Park C, Hwang HJ, Hong SH, Kim GY, Cho EJ, Kim WJ and Choi YH: Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells. Int J Oncol. 49:1009–1018. 2016. View Article : Google Scholar : PubMed/NCBI
5	Du G, Han G, Zhang S, Lin H, Wu X, Wang M, Ji L, Lu L, Yu L and Liang W: Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1alpha inhibition. Eur J Pharmacol. 630:121–130. 2010. View Article : Google Scholar
6	Chen M, Lai L, Li X, Zhang X, He X, Liu W, Li R, Ke X, Fu C, Huang Z and Duan C: Baicalein attenuates neurological deficits and preserves blood-brain barrier integrity in a rat model of intracerebral hemorrhage. Neurochem Res. 41:3095–3102. 2016. View Article : Google Scholar : PubMed/NCBI
7	Chao JI, Su WC and Liu HF: Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol Cancer Ther. 6:3039–3048. 2007. View Article : Google Scholar : PubMed/NCBI
8	Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
9	Bie B, Sun J, Guo Y, Li J, Jiang W, Yang J, Huang C and Li Z: Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomed Pharmacother. 93:1285–1291. 2017. View Article : Google Scholar : PubMed/NCBI
10	Su G, Chen H and Sun X: Baicalein suppresses non small cell lung cancer cell proliferation, invasion and Notch signaling pathway. Cancer Biomark. 22:13–18. 2018. View Article : Google Scholar : PubMed/NCBI
11	Takahashi H, Chen MC, Pham H, Angst E, King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et al: Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta. 1813:1465–1474. 2011. View Article : Google Scholar : PubMed/NCBI
12	Yan W, Ma X, Zhao X and Zhang S: Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro. Drug Des Devel Ther. 12:3961–3972. 2018. View Article : Google Scholar : PubMed/NCBI
13	Chiu YW, Lin TH, Huang WS, Teng CY, Liou YS, Kuo WH, Lin WL, Huang HI, Tung JN, Huang CY, et al: Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol Appl Pharmacol. 255:316–326. 2011. View Article : Google Scholar : PubMed/NCBI
14	Mu J, Liu T, Jiang L, Wu X, Cao Y, Li M, Dong Q, Liu Y and Xu H: The traditional chinese medicine baicalein potently inhibits gastric cancer cells. J Cancer. 7:453–461. 2016. View Article : Google Scholar : PubMed/NCBI
15	Li B, Lu M, Jiang XX, Pan MX, Mao JW and Chen M: Inhibiting reactive oxygen species-dependent autophagy enhanced baicalein-induced apoptosis in oral squamous cell carcinoma. J Nat Med. 71:433–441. 2017. View Article : Google Scholar : PubMed/NCBI
16	Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, Chang NW and Lin C: Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol Appl Pharmacol. 263:360–367. 2012. View Article : Google Scholar : PubMed/NCBI
17	Suske G, Bruford E and Philipsen S: Mammalian SP/KLF transcription factors: Bring in the family. Genomics. 85:551–556. 2005. View Article : Google Scholar : PubMed/NCBI
18	Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC and Xie K: Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61:4143–4154. 2001.PubMed/NCBI
19	Abdelrahim M, Smith R III, Burghardt R and Safe S: Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res. 64:6740–6749. 2004. View Article : Google Scholar : PubMed/NCBI
20	Tan NY and Khachigian LM: Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 29:2483–2488. 2009. View Article : Google Scholar : PubMed/NCBI
21	Safe S and Abdelrahim M: Sp transcription factor family and its role in cancer. Eur J Cancer. 41:2438–2448. 2005. View Article : Google Scholar : PubMed/NCBI
22	Hsieh MJ, Chen JC, Yang WE, Chien SY, Chen MK, Lo YS, His YT, Chuang YC, Lin CC and Yang SF: Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-kB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition. Biochem Pharmacol. 130:10–20. 2017. View Article : Google Scholar : PubMed/NCBI
23	Zhang Y, Wang H, Liu Y, Wang C, Wang J, Long C, Guo W and Sun X: Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Biomed Pharmacother. 102:1003–1014. 2018. View Article : Google Scholar : PubMed/NCBI
24	Zhou H, Liu Y, Wang C, Liu L, Wang H, Zhang Y, Long C and Sun X: Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells. J Exp Clin Cancer Res. 37:1922018. View Article : Google Scholar : PubMed/NCBI
25	Zhou H, Guo W, Long C, Wang H, Wang J and Sun X: Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1. Biochem Biophys Res Commun. 456:815–820. 2015. View Article : Google Scholar
26	Banerjee S, Sangwan V, McGinn O, Chugh R, Dudeja V, Vickers SM and Saluja AK: Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1. J Biol Chem. 288:33927–33938. 2013. View Article : Google Scholar : PubMed/NCBI
27	Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu TT, Mansfield P, Ajani J and Xie K: Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res. 10:4109–4117. 2004. View Article : Google Scholar : PubMed/NCBI
28	Enya K, Hayashi H, Takii T, Ohoka N, Kanata S, Okamoto T and Onozaki K: The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitu-tive gene expression of IL-1 alpha in human melanoma cells. J Leukoc Biol. 83:190–199. 2008. View Article : Google Scholar
29	Shin JA, Kim JJ, Choi ES, Shim JH, Ryu MH, Kwon KH, Park HM, Seo JY, Lee SY, Lim DW, et al: In vitro apoptotic effects of methanol extracts of dianthus chinensis and acalypha australis L. targeting specificity protein 1 in human oral cancer cells. Head Neck. 35:992–998. 2013. View Article : Google Scholar
30	Fox JT, Sakamuru S, Huang R, Teneva N, Simmons SO, Xia M, Tice RR, Austin CP and Myung K: High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc Natl Acad Sci USA. 109:5423–5428. 2012. View Article : Google Scholar : PubMed/NCBI
31	Yu J, Liu H, Lei J, Tan W, Hu X and Zou G: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 21:817–822. 2007. View Article : Google Scholar : PubMed/NCBI
32	Gong WY, Zhao ZX, Liu BJ, Lu LW and Dong JC: Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors. Eur J Med Chem. 126:844–852. 2017. View Article : Google Scholar
33	Baumann S, Fas SC, Giaisi M, Müller WW, Merling A, Gülow K, Edler L, Krammer PH and Li-Weber M: Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. Blood. 111:2354–2363. 2008. View Article : Google Scholar
34	Zhou QM, Wang S, Zhang H, Lu YY, Wang XF, Motoo Y and Su SB: The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol Sin. 30:1648–1658. 2009. View Article : Google Scholar : PubMed/NCBI
35	Gao J, Morgan WA, Sanchez-Medina A and Corcoran O: The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. Toxicol Appl Pharmacol. 254:221–228. 2011. View Article : Google Scholar : PubMed/NCBI
36	Ling Y, Chen Y, Chen P, Hui H, Song X, Lu Z, Li C, Lu N and Guo Q: Baicalein potently suppresses angiogenesis induced by vascular endothelial growth factor through the p53/Rb signaling pathway leading to G1/S cell cycle arrest. Exp Biol Med (Maywood). 236:851–858. 2011. View Article : Google Scholar
37	Chen CH, Huang TS, Wong CH, Hong CL, Tsai YH, Liang CC, Lu FJ and Chang WH: Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem Toxicol. 47:638–644. 2009. View Article : Google Scholar : PubMed/NCBI
38	Dou J, Wang Z, Ma L, Peng B, Mao K, Li C, Su M, Zhou C and Peng G: Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget. 9:20089–20102. 2018. View Article : Google Scholar : PubMed/NCBI
39	Tian Y, Zhen L, Bai J, Mei Y, Li Z, Lin A and Li X: Anticancer effects of baicalein in pancreatic neuroendocrine tumors in vitro and in vivo. Pancreas. 46:1076–1081. 2017. View Article : Google Scholar : PubMed/NCBI
40	Sachita K, Yu HJ, Yun JW, Lee JS and Cho SD: YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines. J Oral Pathol Med. 44:785–791. 2015. View Article : Google Scholar
41	Cho JH, Lee RH, Jeon YJ, Shin JC, Park SM, Choi NJ, Seo KS, Yoon G, Cho SS, Kim KH, et al: Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft. Int J Biochem Cell Biol. 64:287–297. 2015. View Article : Google Scholar : PubMed/NCBI
42	Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, Vilela RJ, Ende K, McCullagh L, Rudy SF, et al: A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck. 27:771–784. 2005. View Article : Google Scholar : PubMed/NCBI
43	Bond M, Fabunmi RP, Baker AH and Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa. B FEBS Lett. 435:29–34. 1998. View Article : Google Scholar
44	Mburu YK, Egloff AM, Walker WH, Wang L, Seethala RR, van Waes C and Ferris RL: Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN). J Biol Chem. 287:3581–3590. 2012. View Article : Google Scholar
45	Lee E, Park HR, Ji ST, Lee Y and Lee J: Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydro-pyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK. J Neurosci Res. 92:130–139. 2014. View Article : Google Scholar
46	Sahu BD, Mahesh Kumar J and Sistla R: Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-κB Pathways. PloS One. 10:e01341392015. View Article : Google Scholar
47	Wan CX, Xu M, Huang SH, Wu QQ, Yuan Y, Deng W and Tang QZ: Baicalein protects against endothelial cell injury by inhibiting the TLR4/NFkB signaling pathway. Mol Med Rep. 17:3085–3091. 2018.
48	Yu X, Liu Y, Wang Y, Mao X, Zhang Y and Xia J: Baicalein induces cervical cancer apoptosis through the NF-κB signaling pathway. Mol Med Rep. 17:5088–5094. 2018.PubMed/NCBI
49	Yu X, Tang W, Yang Y, Tang L, Dai R, Pu B, Feng C and Xia J: Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling. Chem Biol Interactions. 285:48–58. 2018. View Article : Google Scholar